hydroxyprogesterone caproate
Commercial- Indications
- Preterm birth prevention
Company intelligence / Profile preview
KV Pharmaceutical was a specialty pharmaceutical company primarily focused on women’s healthcare. It developed and marketed both branded and generic drugs with an emphasis on unique drug delivery systems. The company faced significant regulatory challenges—including FDA shutdowns for compliance issues—and filed for Chapter 11 bankruptcy in August 2012. It emerged from bankruptcy in September 2013 but ultimately ceased operations.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KV Pharmaceutical Company.